It's an increasingly common scenario. You fill in an online form to request an appointment with a doctor, and back comes a ...

Learn when you can refuse to give your Social Security number and protect from identity theft. Not every SSN request is ...

The back-and-forth between the FDA and gene therapy developer uniQure is getting messier, with an agency spokesperson now denying the biotech’s claims about a sham trial request for the rare ...

Total revenue -- $128.6 million in the fiscal fourth quarter ended Dec. 31, 2025, with primary growth from DEFENCATH and the first full-quarter contribution from the Melinta portfolio. Fiscal 2026 ...

Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year ...

With more than 1.2 million B.C. residents on waitlists to see a specialist, doctors say the budget has no dedicated funding ...

Good morning, and welcome to the CorMedix Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Leading the call tod ...

The Approved Costing Guidance explains how NHS trusts should cost at patient level using the costing standards and then submit cost data for the financial year 2025/26 using the National Cost ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

Ifetroban Clinical Progress -- Phase II FIGHT DMD trial showed high-dose treatment improved LVEF by 3.3% versus placebo and 5.4% over propensity-matched controls, with Fast Track, Orphan Drug, and ...

Produce prescriptions and hospital food programs are expanding fast. But the real test isn’t medical—it’s financial.

Iris Sharma, a 38-year-old B.C. teacher, began experiencing severe neurological symptoms in the summer of 2023, including ...